Peptide therapy on TikTok: separating signal from hype

What did @skinbydrazi actually say?

The creator opened with a refreshingly skeptical take: "most of them are overrated" and called out "peptide marketing fluff." From there, they broke down three categories of topical peptides: signaling peptides that tell fibroblasts to produce collagen, copper peptides for wound healing and inflammation, and neuropeptides like Snap-8 that reduce muscle contraction to soften expression lines. They also made a specific absorption argument, suggesting peptides work better in eye and lip products because the skin is thinner there. The video ended with a plug for two FormBlends products containing palmitoyl tetrapeptides.

The framing is more grounded than most peptide content on TikTok, but a few claims need closer inspection. The absorption logic is directionally correct but oversimplified. The Snap-8 claim repeats an industry talking point that has very thin independent research behind it.

Does the science back this up?

For signaling peptides like palmitoyl pentapeptide-4 (Matrixyl), yes, there is legitimate data. A study by Robinson et al. (2005, International Journal of Cosmetic Science) found measurable increases in collagen synthesis in ex vivo skin models. That is not the same as a randomized clinical trial, but it is real mechanistic evidence. Copper peptide GHK-Cu has decent support for wound healing contexts, with Pickart and Margolina (2018, Cosmetics) summarizing decades of research on its role in tissue remodeling.

The claim that thinner periorbital and perioral skin improves peptide absorption is plausible. Transepidermal water loss is higher around the eyes, and stratum corneum thickness varies across facial regions (Harding et al., 2000, Contact Dermatitis). But thinner skin also means a more fragile barrier, which is not automatically a delivery advantage. Formulation vehicle matters more than skin thickness alone.

What did they get wrong (or right)?

They got the skepticism right. The peptide supplement and skincare space is genuinely overclaimed, and leading with "most of them are overrated" is accurate given the current evidence base.

The Snap-8 claim is where things get shakier. Snap-8 is an octapeptide marketed as a topical alternative to botulinum toxin, supposedly blocking neurotransmitter release to reduce muscle contraction. The creator says it can "relax the muscles so you're not scratching up the skin." The mechanism sounds compelling, but the evidence is almost entirely from manufacturer-funded in vitro studies. No independent peer-reviewed clinical trial has confirmed meaningful muscle relaxation from topical Snap-8 at cosmetically relevant concentrations. Calling it a neuropeptide is technically accurate; claiming it meaningfully relaxes facial muscles through topical application is not well-supported.

The collagen signaling claim for palmitoyl tetrapeptides is the best-supported claim in the video. Studies including Lintner and Mas-Chamberlin (2002, Journal of Cosmetic Science) show real fibroblast stimulation in vitro.

What should you actually know?

Topical peptides are not fake, but they are also not interchangeable. The evidence hierarchy matters here. Palmitoyl-based signaling peptides have the most independent research behind them. Copper peptides have solid wound-healing data but most studies are in post-procedure or compromised skin contexts, not intact skin with a full barrier. Neuropeptides like Snap-8 are largely riding manufacturer claims.

Absorption remains the central unsolved problem with peptide skincare. Peptides are hydrophilic and relatively large molecules, which means most do not passively cross an intact stratum corneum in meaningful amounts. Formulation, including lipid carriers, encapsulation, and pH, determines whether any peptide reaches its target. A peptide in a poorly formulated product is largely inert regardless of how good the peptide itself is in a lab setting. The creator mentioned this correctly but briefly.

• Look for independent clinical data, not just in vitro or brand-funded studies.
• Post-procedure application (compromised barrier) is a different context than daily use on intact skin.
• Concentration and vehicle are as important as the peptide itself.
• Eye and lip areas have some anatomical rationale for better delivery, but formulation still dominates.